Comparison of PathVysion and INFORM Fluorescence In Situ Hybridization Kits for Assessment of HER-2/neu Status in Breast Carcinoma

被引：0
|
作者：
Sanjay Kakar
Nick Puangsuvan
Jane M. Stevens
Romualda Serenas
George Mangan
Shalini Sahai
Michael L. Mihalov
机构：
[1] University of Illinois at Chicago,Department of Pathology
来源：
Molecular Diagnosis | 2000年 / 5卷 / 3期
关键词：
PathVysion; INFORM; prognosis; immunohistochemistry;
D O I：
10.1007/BF03262076
中图分类号：
学科分类号：
摘要：
Background: Fluorescence in situ hybridization is advocated for precise assessment of HER-2/neu status in breast carcinoma; however, few objective data compare available kits for clinical laboratories contemplating development of the test.
引用
收藏
页码：193 / 197
页数：4
相关论文
共 50 条
  • [41] Detection of HER-2/neu gene amplification by fluorescence in situ hybridization in human breast cancer
    Coupier, I
    Llorca, FP
    Perissel, B
    Tchirkov, A
    Malet, P
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 120 - 120
  • [42] The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer
    Mitchell, MS
    Press, MF
    SEMINARS IN ONCOLOGY, 1999, 26 (04) : 108 - 116
  • [43] Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization
    Persons, DL
    Borelli, KA
    Hsu, PH
    MODERN PATHOLOGY, 1997, 10 (07) : 720 - 727
  • [44] HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
    Bozzetti, C
    Personeni, N
    Nizzoli, R
    Guazzi, A
    Flora, M
    Bassano, C
    Negri, F
    Martella, E
    Naldi, N
    Franciosi, V
    Cascinu, S
    CANCER CYTOPATHOLOGY, 2003, 99 (05): : 310 - 315
  • [45] Fluorescence in situ hybridization for HER-2/neu amplification of breast carcinoma in archival fine needle aspiration biopsy specimens
    Gu, M
    Ghafari, S
    Zhao, MX
    ACTA CYTOLOGICA, 2005, 49 (05) : 471 - 476
  • [46] Her-2/neu status in endometrial carcinomas: Comparison of quantitative immunohistochemistry by automated cellular imaging and fluorescence in situ hybridization
    Xu, B
    Wallace, J
    Li, C
    Woda, B
    Khan, A
    MODERN PATHOLOGY, 2005, 18 : 209A - 209A
  • [47] Her-2/neu status in endometrial carcinomas: Comparison of quantitative immunohistochemistry by automated cellular imaging and fluorescence in situ hybridization
    Xu, B
    Wallace, J
    Li, C
    Moda, B
    Khan, A
    LABORATORY INVESTIGATION, 2005, 85 : 209A - 209A
  • [48] Assessment of HER-2/neu status in breast cancer using fluorescence in situ hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre in India
    Panjwani, Poonam
    Epari, Sridhar
    Karpate, Arti
    Shirsat, Hemlata
    Rajsekharan, Preetha
    Basak, Ranjan
    Shet, Tanuja
    Chinoy, Roshni
    Chacko, Roy
    Gursale, Sampada
    Baraskar, Nayana
    Gupta, Sudeep
    Hawaldar, Rohini
    Desai, Sangeeta
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (03) : 287 - 294
  • [49] HER-2/neu analysis in archival tissue samples of human breast cancer:: Comparison of immunohistochemistry and fluorescence in situ hybridization
    Lebeau, A
    Deimling, D
    Kaltz, C
    Sendelhofert, A
    Iff, A
    Luthardt, B
    Untch, M
    Löhrs, U
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 354 - 363
  • [50] HER-2/neu status in breast carcinoma:: Immunohistochemistry vs. gene amplification by fluorescent in situ hybridization (FISH)
    Khan, A
    Pihan, G
    Witkiewicz, A
    Edmiston, K
    Savas, L
    Reale, F
    MODERN PATHOLOGY, 2001, 14 (01) : 29A - 29A
12345